Synthesis of biologically active taxoids

K. C. Nicolaou, R. K. Guy

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review


Taxol® (Figure 7.1; 1), a diterpene originally isolated from the American Pacific yew Taxus brevifolia,1 has emerged as one of the most effective chemotherapeutic agents for the treatment of breast and ovarian cancers.2 The compound is also in development for non-small-cell lung cancers,3 and head and neck cancers.4 Taxol’s development has included periods of both unusual languor and speed.5 It acts by blocking the normal depolymerization of microtubules, a process that is crucial for a number of cellular functions including mitosis.6 The elucidation of this unique mechanism by Horwitz’s group in the early 1980s spurred the drug’s development.7.

Original languageEnglish
Title of host publicationChemistry and Molecular Aspects of Drug Design and Action
Number of pages8
ISBN (Electronic)9781420008272
StatePublished - Jan 1 2008

Bibliographical note

Publisher Copyright:
© 2008 by Taylor & Francis Group, LLC.

ASJC Scopus subject areas

  • General Chemistry
  • General Pharmacology, Toxicology and Pharmaceutics
  • General Medicine


Dive into the research topics of 'Synthesis of biologically active taxoids'. Together they form a unique fingerprint.

Cite this